Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

50 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Acute Symptoms of Chronic Bronchitis

NCT00644449

Conditions
Bronchial Diseases, Bronchitis, Bronchitis, Chronic, +10 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Columbiana, Alabama, United States
  • Pfizer Investigational Site Tallassee, Alabama, United States
View all 75 locations
View Trial Details
Completed

A Trial To Evaluate Two Antibiotics For The Treatment Of Acute Exacerbation Of Chronic Bronchitis (AECB)

NCT00254566

Conditions
Bronchial Diseases, Bronchitis, Bronchitis, Chronic, +11 more
Locations
  • Pfizer Investigational Site Guangzhou, Guangdong, China
  • Pfizer Investigational Site Shijiazhuang, Hebei, China
  • Pfizer Investigational Site Nanjing, Jiangsu, China
  • Pfizer Investigational Site Shenyang, Liaoning, China
View all 34 locations
View Trial Details
Completed

A Multicentre, Randomised, Open-Label Study To Compare The Efficacy And Safety Of Azithromycin For 5 Days With Those Of Amoxicillin-Clavulanic Acid In Patients With Chronic Bronchitis

NCT00649831

Conditions
Bronchial Diseases, Bronchitis, Bronchitis, Chronic, +10 more
Locations
  • Pfizer Investigational Site Anzin, France
  • Pfizer Investigational Site Avignon, France
  • Pfizer Investigational Site Avignon, France
  • Pfizer Investigational Site Dijon, France
View all 31 locations
View Trial Details
Completed

Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)

NCT00153634

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Bronchial Diseases, +21 more
Locations
  • University of Iowa Iowa City, Iowa, United States
  • Washington University St. Louis St Louis, Missouri, United States
  • University of Cincinnati Cincinnati, Ohio, United States
  • Ohio State University Columbus, Ohio, United States
View Trial Details
Completed

Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency

NCT00460096

Conditions
Alpha 1-Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • National Jewish Medical and Research Center Denver, Colorado, United States
  • University of Florida School of Medicine Gainesville, Florida, United States
  • The University of Texas Health Center at Tyler Tyler, Texas, United States
View Trial Details

Related conditions